Clinical Trials Logo

Filter by:
NCT ID: NCT05433077 Active, not recruiting - Quality of Life Clinical Trials

Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal Environment

PACTHE-VR
Start date: June 27, 2022
Phase:
Study type: Observational

The PACThe - Real life project is a post-therapeutic support and rehabilitation for women in complete remission of breast cancer in a thermal environment. It consists of a 3 weeks spa treatment for patients in remission of breast cancer. This stay in spa treatment will be an adapted "post-cancer" support and has the main objective of showing a lasting improvement in the quality of life following the program offered to women following their breast cancer treatments. The evaluation of the quality of life will be done using the SF-36 self-questionnaire which will be completed by the patients 5 times (inclusion visit, end of the spa stay, 6 months post-cure, 12 months post-cure and 18 months post-cure).

NCT ID: NCT05432687 Recruiting - Prostate Cancer Clinical Trials

Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO)

PROSTABDO
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

the aim of this study is assess deep abdominal wall (ultrasonography of transversus abdominis muscle) before prostatectomy, and look at one year post surgery if patient with several incontinence are the same who have dysfunction (abdominal incompetence) before the surgery.

NCT ID: NCT05432336 Recruiting - Keratitis Clinical Trials

Complex Ocular Infection, Optimization of Microbiological Diagnosis

ICODIA
Start date: November 21, 2023
Phase:
Study type: Observational

The purpose of this study is to evaluate the impact of different technique to optimize the microbiological diagnosis of the COI. - Metagenomic for the endophtalmitis - Multiplex polymerase chain reaction for corneal abscesses

NCT ID: NCT05432323 Recruiting - School Phobia Clinical Trials

Multi-family Therapy and School Refusal: an Exploratory Study With Adolescents and Their Families

Multi-Fast
Start date: September 12, 2022
Phase:
Study type: Observational

The purpose of this study is to determine whether multi-family therapy is effective in the treatment of school refusal with anxiety in adolescence.

NCT ID: NCT05431985 Completed - Chronic Pain Clinical Trials

Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care

VAMOS
Start date: January 1, 2017
Phase:
Study type: Observational

Objective: Analgesic Opioids misuse among patients with chronic pain ranges from 0% to 50%. The general practitioner is the first prescriber of opioid analgesics Our objective was to validate in primary care the POMI (Prescription Opioid Misuse Index) to identify the misuse of AOs. Study Setting: Patients with chronic pain, taking AOs for at least 3 months, and followed in general practice. Study design: Psychometric study Data Collection/Extraction methods: Eligible patients followed in general practice responded to the POMI: Test phase. They then responded after 2 weeks: the retest. The gold standard used was the DSM-V.

NCT ID: NCT05431738 Not yet recruiting - Clinical trials for GastroEsophageal Cancer

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

ANTIMIG
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.

NCT ID: NCT05430893 Completed - Athletic Pubalgia Clinical Trials

Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia

PUBATOX
Start date: June 1, 2017
Phase:
Study type: Observational

Chronic athletic pubalgia is a frequent sport condition in which the effectiveness of medical treatment has not been proven. Intra-muscular injection of botulinum toxin A may have positive effects on pain in some chronic tendinitis. The investigators hypothesized that similar analgesic effect of intra-muscular botulinum toxin A may be observed in individuals with chronic AP. In the present study, the investigators aimed to describe the short-term evolution of pain and of activity limitations and quality of life, after an injection of the adductor longus with botulinum toxin A, in individuals with chronic AP, for whom medical and/or surgical treatments have failed.

NCT ID: NCT05430880 Not yet recruiting - Clinical trials for VCO2 Variation in Intensive Care as a Marker of Fluid Responsiveness

Cardiac Responsiveness Assessment by CO2

CRAC
Start date: September 1, 2022
Phase:
Study type: Observational [Patient Registry]

The increase of cardiac output resulting from increased blood volume (systolic ejection volume) during intravenous fluid administration defines a state of fluid responsiveness. Fluid responsiveness in intensive care patients with circulatory failure (shock) needs to be carefully evaluated because only half of the patients are fluid responsive and excessive fluid administration is harmful. To reliably assess this state, it is currently necessary to perform either invasive cardiac output monitoring or ultrasound evaluation before and after a fluid administration (called fluid challenge). It is either an invasive procedure or a time-consuming technique (that might depend on operator experience and patient echogenicity). The investigators foresee a potential benefit for an objective quick-answering screening tool that does not require additional monitoring. Instantaneous CO2 production rate (VCO2) calculated automatically by the most recent ventilators (Hamilton C5-C6) via the analysis of exhaled gases. There is an established physiological link between cardiac output, arterial oxygen transport to cells and CO2 production by cell metabolism. The variation in End-Tidal CO2 (another parameter derived from exhaled CO2) is conventionally monitored in the operating room; it can show sudden changes in cardiac output. In intensive care, the EtCO2 variation is probably less sensitive than the variation in VCO2 to detect changes in cardiac output. The aim of this study is to show that the variation in VCO2 as shown on ventilators during a fluid challenge test has satisfactory diagnostic performance in the detection of fluid responsiveness in patients with circulatory failure in intensive care.

NCT ID: NCT05429853 Recruiting - Malnutrition Clinical Trials

TOLER-ENT Study: A Study to Investigate the Tolerance of the High Energy, High Protein Formula Sondalis® HP 2 kcal

SONDALIS
Start date: July 8, 2022
Phase: N/A
Study type: Interventional

A multicentre, prospective, open-label, single arm study for 2 months, involving adult patients under poorly tolerated Home Enteral Nutrition (HEN). The study aims to analyse the evolution of tolerance and quality of life of HEN patients after switching from a High Protein High Energy (HPHE) polymeric Enteral Nutrition (EN) formula with or without fibre to Sondalis® HP 2kcal, with or without fibre. Eligible patients will give their written consent to participate before being included into the study.

NCT ID: NCT05429762 Terminated - Neoplasm Clinical Trials

Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors

TusaRav-QT
Start date: October 3, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase1, single-arm study for treatment. This is a prospective multicenter, multinational, open-label study to assess the effect of tusamitamab ravtansine on the QT interval in participants with metastatic colorectal cancer (CRC), nonsquamous non small cell lung cancer (NSQ NSCLC), or gastric/ gastroesophageal junction (GEJ) adenocarcinoma for which in the judgement of the Investigator, no standard alternative therapy is available.